| Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization and applications S Bhupinder, S Bandyopadhyay, R Kapil, ... Critical Reviews in Therapeutic Drug Carrier Systems 26 (5), 427-521, 2009 | 255 | 2009 |
| Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides S Bandyopadhyay, OP Katare, B Singh Colloids and Surfaces B: Biointerfaces 100, 50-61, 2012 | 159 | 2012 |
| Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol B Singh, R Singh, S Bandyopadhyay, R Kapil, B Garg Colloids and Surfaces B: Biointerfaces 101, 465-474, 2013 | 136 | 2013 |
| Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential B Singh, L Khurana, S Bandyopadhyay, R Kapil, OOP Katare Drug Delivery 18 (8), 599-612, 2011 | 93 | 2011 |
| Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters S Bandyopadhyay, OP Katare, B Singh Expert opinion on drug delivery 11 (4), 479-492, 2014 | 32 | 2014 |
| Systematic development of optimized SNEDDS of artemether with improved biopharmaceutical and antimalarial potential CB Tripathi, S Beg, R Kaur, G Shukla, S Bandopadhyay, B Singh Drug delivery 23 (9), 3209-3223, 2016 | 30 | 2016 |
| QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques S Beg, S Saini, S Bandopadhyay, OP Katare, B Singh Drug development and industrial pharmacy 44 (3), 407-420, 2018 | 29 | 2018 |
| QbD-oriented development of self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharmaceutical performance S Bandyopadhyay, S Beg, O P Katare, G Sharma, B Singh Current drug delivery 12 (5), 544-563, 2015 | 21 | 2015 |
| An explicit review on quantitative estimation of candesartan cilexetil employing various analytical techniques S Bandyopadhyay, L Bhuria, D Lal Pharma Anal Acta 4 (6), 1-7, 2013 | 11 | 2013 |
| A review on the medicinal importance of pomegranate MV Fateh, S Ahmed, M Ali, S Bandyopadhyay Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical …, 2013 | 9 | 2013 |
| Overview of different carrier systems for advanced drug delivery S Bandopadhyay, S Manchanda, A Chandra, J Ali, PK Deb Drug Delivery Systems, 179-233, 2020 | 8 | 2020 |
| Pre-Formulation Studies of Drug Substances, Protein and Peptides: Role in Drug Discovery and Pharmaceutical Product Development S Bandopadhyay, N Bandyopadhyay, C Singh, PK Deb, RK Tekade Dosage Form Design Considerations 1, 401-433, 2018 | 7 | 2018 |
| Endeavoring biowaivers using BCS and IVIVC B Singh, A Mohapatra, S Bandyopadhyay, R Kapil The Pharma Review 8 (43), 87-93, 2010 | 5 | 2010 |
| Systematic optimization of drug delivery systems: an insight B Singh, S Bandyopadhyay, R Kapil, N Ahuja The Pharma Review 7 (37), 146-152, 2008 | 5 | 2008 |
| Nanocarriers in different preclinical and clinical stages SN Abed, PK Deb, HS Surchi, SF Kokaz, SM Jamal, S Bandopadhyay, ... Basic Fundamentals of Drug Delivery, 685-731, 2019 | 4 | 2019 |
| Formulation Additives used in Pharmaceutical Products: Emphasis on Regulatory Perspectives and GRAS S Manchanda, A Chandra, S Bandopadhyay, PK Deb, RK Tekade Dosage Form Design Considerations 1, 773-831, 2018 | 4 | 2018 |
| Handling Poorly Bioavailable Drugs Using Nanoemulsifying Drug Delivery Systems B Singh, S Bandyopadhyay, S Beg, OP Katare The Pharma Review 9 (54), 91-98, 2011 | 4 | 2011 |
| Nanostructured lipid carriers as novel drug delivery vehicles B Singh, S Bandyopadhyay, R Kapil, OP Katare Pharma Buzz 3 (10), 38-46, 2008 | 4 | 2008 |
| Design and fabrication of transdermal/skin drug-delivery system RK Keservani, S Bandopadhyay, N Bandyopadhyay, AK Sharma Drug Delivery Systems, 131-178, 2020 | 3 | 2020 |
| Perspective and potential of A2A and A3 adenosine receptors as therapeutic targets for the treatment of rheumatoid arthritis Y Pal, N Bandyopadhyay, RS Pal, S Ahmed, S Bandopadhyay Current pharmaceutical design 25 (26), 2859-2874, 2019 | 3 | 2019 |
Professor Bhupinder Singh BhoopUniv Inst Pharm Sci & Coordinator, Nat UGC Excellence Centre NanoBiomedicine, Panjab Univ, IndiaVerified email at pu.ac.in
